Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Inovio Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Inovio Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Yarno Wendy L | Director | 10,512 | May 21, 2026 | 1 |
| Kies Peter | CFO | 42,854 | May 21, 2026 | 4 |
| Benito Simon X | Director | 12,191 | May 21, 2026 | 1 |
| Zoth Lota S. | Director | 8,726 | May 21, 2026 | 1 |
| Shepard Jay | Director | 9,209 | May 21, 2026 | 1 |
| Weiner David B. | Director | 87,592 | May 21, 2026 | 2 |
| Dansey Roger D | Director | 8,916 | May 21, 2026 | 1 |
| Humeau Laurent | Chief Scientific Officer | 46,823 | May 21, 2026 | 4 |
| Miller Ann Calby | Director | 9,877 | May 21, 2026 | 1 |
| Shea Jacqueline Elizabeth | Chief Executive Officer | 111,021 | May 21, 2026 | 4 |
| Sumner Michael John | Chief Medical Officer | 42,038 | May 21, 2026 | 5 |
| Kim Jong Joseph | Chief Executive Officer | 1,422,627 | Mar 14, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 (view filing) | Jun 5 | Same day | Zoth Lota S.Director | SSale | −5.70K | $0.56 | −$3.19K | −9.8%52.7K after | |
| Mar 13, 2023 (view filing) | Mar 13 | Same day | Weiner David B.Director | SSale | −5.83K | $1.15 | −$6.71K | −0.6%910.1K after | |
| Feb 28, 2023 (view filing) | Feb 27 | 1 day | Weiner David B.Director | SSale | −11.7K | $1.28 | −$14.9K | −1.3%904.3K after | |
| Aug 11, 2022 (view filing) | Aug 11 | Same day | Weiner David B.Director | SSale | −11.9K | $2.66 | −$31.6K | −1.3%892.6K after | |
| Jul 20, 2022 (view filing) | Jul 20 | Same day | Benito Simon XDirector | SSale | −2.00K | $2.25 | −$4.50K | −2.6%75.3K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Weiner David B.Director | SSale | −9.00K | $1.95 | −$17.6K | −1.0%892.6K after | |
| May 17, 2022 (view filing) | May 16 | 1 day | Zoth Lota S.Director | SSale | −3.60K | $1.98 | −$7.13K | −8.4%39.4K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Benito Simon XDirector | SSale | −2.00K | $3.16 | −$6.32K | −3.4%57.3K after | |
| Mar 14, 2022 (view filing) | Mar 14 | Same day | Weiner David B.Director | SSale | −4.08K | $3.20 | −$13.1K | −0.5%883.6K after | |
| Mar 9, 2022 (view filing) | Mar 9 | Same day | Weiner David B.Director | SSale | −4.08K | $3.33 | −$13.6K | −0.5%876.0K after | |
| Jan 21, 2022 (view filing) | Jan 19 | 2 days | Benito Simon XDirector | SSale | −2.00K | $4.27 | −$8.54K | −3.4%57.3K after | |
| Jan 5, 2022 (view filing) | Jan 5 | Same day | Zoth Lota S.Director | SSale | −961 | $5.01 | −$4.81K | −3.7%25.0K after | |
| Aug 11, 2021 (view filing) | Aug 9 | 2 days | Humeau LaurentChief Scientific Officer | SSale | −10.3K | $9.15 | −$94.4K | −13.1%68.6K after |